The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2

Hong, Cynthia, Duit, Sarah, Jalonen, Pilvi, Out, Ruud, Scheer, Lilith, Sorrentino, Vincenzo, Boyadjian, Rima, Rodenburg, Kees W. +7 more·2010·Journal of Biological Chemistry
DOI 10.1074/jbc.m110.123729

Cited by (142)

Items 101–142 of 142

  1. MYLIP attenuates hypoxia tolerance by inducing K27-linked polyubiquitination and subsequent proteasomal degradation of HIF-α
    Jun Li, Zhi Li, Xiong Li, Ziyi Li, Yanan Song, Le Yuan, Yanyi Wang, Runkun Yan, Fuxiang Lai, Jing Wang et al. · 2025 · Communications Biology
  2. Liver X Receptor-Inducible Host E3 Ligase IDOL Targets a Human Cytomegalovirus Reactivation Determinant
    Luwanika Mlera, Donna K. Collins-McMillen, Sebastian Zeltzer, Jason Buehler, Melissa A. Moy, Kristen Zarrella, Katie Caviness, Louis Cicchini, David J. Tafoya, Felicia D. Goodrum · 2023 · Journal of Virology
  3. The interaction between HCV and nuclear receptor-mediated pathways
    Zoe Raglow, Carly Thoma-Perry, Richard K. Gilroy, Yu‐Jui Yvonne Wan · 2011 · Pharmacology & Therapeutics
  4. Targeting NPC1 in Renal Cell Carcinoma
    Rushaniya Fazliyeva, Peter B. Makhov, Robert G. Uzzo, Vladimir M. Kolenko · 2024 · Cancers
  5. Lipoprotein Receptors
    Wolfgang J. Schneider · 2015 · Elsevier eBooks
  6. Kratom leaf extracts exert hypolipidaemic effects via the modulation of PCSK9 and LDLR pathways in HepG2 cells
    Nantiya Nawaka, Monthon Lertcanawanichakul, Sureerut Porntadavity, Burabha Pussadhamma, Nutjaree Jeenduang · 2025 · Scientific Reports
  7. Fresh and Browned Lotus Root Extracts Promote Cholesterol Metabolism in FFA-Induced HepG2 Cells through Different Pathways
    Shuyuan Zhong, Jingfang Li, Teng Wei, Zeyuan Deng, Xiaoru Liu · 2023 · Foods
  8. Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?
    Andrea Volta, G. Kees Hovingh, Aldo Grefhorst · 2018 · Current Opinion in Lipidology
  9. IDOL in metabolic, neurodegenerative and cardiovascular disease
    Nienke M. van Loon, Patrick C.N. Rensen, Noam Zelcer · 2018 · Aging
  10. Zebrafish mylipb attenuates antiviral innate immunity through two synergistic mechanisms targeting transcription factor irf3
    Zhi Li, Jun Li, Ziyi Li, Yanan Song, Yanyi Wang, Chunling Wang, Le Yuan, Wuhan Xiao, Jing Wang · 2024 · PLoS Pathogens
  11. Insights into the suitability of utilizing brown rats (Rattus norvegicus) as a model for healing spinal cord injury with epidermal growth factor and fibroblast growth factor-II by predicting protein-protein interactions
    Nashira Grigg, Andrew Schoenrock, Kevin Dick, James R. Green, Ashkan Golshani, Alex Wong, Frank Dehne, Eve Chung Tsai, Kyle K. Biggar · 2018 · Computers in Biology and Medicine
  12. Fatty Acids - From Biosynthesis to Human Health
    Erik Froyen · 2022 · Biochemistry
  13. The Gut Microbiota and Atherosclerosis: The State of the Art and Novel Perspectives
    Giulio La Rosa, Luigi Marzio Biasucci · 2016 · Cardiovascular Innovations and Applications
  14. Macrophage Foam Cells
    Annabel F. Valledor, Jorge Lloberas, Antonio Celada · 2015 · Encyclopedia of Life Sciences
  15. CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
    Sayan Mullick Chowdhury, Feng Hong, Christian Diego Rolfo, Zihai Li, Kai He, Robert Wesolowski, Amir Mortazavi, Lingbin Meng · 2025 · Biology
  16. IDOL Deficiency Inhibits Cholesterol-Rich Diet–Induced Atherosclerosis in Rabbits
    Tomonari Koike, Yui Koike, Manabu Niimi, Yanhong Guo, Dongshan Yang, Jun Whi Song, Jie Xu, Xiangming Tang, Zhuoying Ren, Xiangbo Kong et al. · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
  17. Idolizing the clearance of Amyloid-β by microglia
    Nienke M. van Loon, Noam Zelcer · 2016 · Annals of Translational Medicine
  18. Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors
    Karahan, Hande, Hartigan, Kelly, Al‐Amin, Md Mamun, John, Sutha K., McCord, Brianne, Wijeratne, H. R. Sagara, Acri, Dominic J., Smith, Daniel C., Dabin, Luke C., Cordero, Hannah M. Rondon et al. · 2025 · Alzheimer's &amp; Dementia
  19. As a matter of fat: Emerging roles of lipid‐sensitive E3 ubiquitin ligases
    Christian M. Gawden‐Bone, Paul J. Lehner, Norbert Volkmar · 2023 · BioEssays
  20. Novel Regulators of Low-Density Lipoprotein Receptor and Circulating LDL-C for the Prevention and Treatment of Coronary Artery Disease
    Guoqing Cao, Robert J., C. Mark, Jian Wang · 2012 · InTech eBooks
  21. Fyn Tyrosine Kinase Increases Apolipoprotein E Receptor 2 Levels and Phosphorylation
    Teal C. Burrell, Shailaja D. Divekar, Edwin J. Weeber, George William Rebeck · 2014 · PLoS ONE
  22. Genetic polymorphism of IDOL gene was associated with the susceptibility of coronary artery disease in Han population in Xinjiang, China
    Dilare Adi, Jialin Abuzhalihan, Jing Tao, Yun Wu, Yinghong Wang, Fen Liu, Yi‐Ning Yang, Xiang Ma, Xiao‐Mei Li, Xiang Xie et al. · 2021 · Hereditas
  23. Transcriptomic Analysis in the Liver of Two Rabbit Lines Divergently Selected for Intramuscular Fat Content
    Jesús Valdés‐Hernández, Agostina Zubiri-Gaitán, Marina Martínez-Álvaro, A. Blasco, Pilar Hernández · 2026 · Animal Genetics
  24. Lipid Metabolism and Associated Molecular Signaling Events in Autoimmune Disease
    Vanditha Mohan, Sonu Das, Mathew John · 2022 · Biochemistry
  25. Understanding Neurodegeneration and Neuroprotection Through Genetic Screens in Drosophila
    Aishwarya S Mandya, Rajit Narayanan Cheramangalam, Manish Jaiswal · 2019 · Springer eBooks
  26. Adeno-Associated Viruses as a Method to Induce Atherosclerosis in Mice and Hamsters
    Noam Zelcer, Marit Westerterp · 2014 · Circulation Research
  27. Mechanisms for and consequences of cellular lipid accumulation - Role of the Very Low Density Lipoprotein (VLDL) receptor
    Jeanna Perman · 2011 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  28. Lipids as New Targets
    Eduardo Domínguez · 2012
  29. Protein turnover regulated by cholesterol
    Mi‐Jurng Kim, Wendy Jessup · 2012 · Current Opinion in Lipidology
  30. Transcriptional and Posttranscriptional Control of Cholesterol Homeostasis by Liver X Receptors
    P. T Ontonoz · 2011
  31. LXR-inducible host E3 ligase IDOL targets a human cytomegalovirus reactivation determinant
    Luwanika Mlera, Donna K. Collins-McMillen, Sebastian Zeltzer, Jason Buehler, Melissa A. Moy, Kristen Zarrella, Katie Caviness, Louis Cicchini, David J. Tafoya, Felicia D. Goodrum · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Curcumin-Nicotinate Attenuates Hippocampal Synaptogenesis Dysfunction in Hyperlipidemia Rats by the BDNF/TrkB/CREB Pathway: Involving Idol/LDLR Signaling to Eliminate Aβ Deposition
    Lin‐Yu Wang, Jiao Liu, Yi-Zhu Peng, Caiping Zhang, Wei Zou, Feng Liu, Ke‐Bin Zhan, Ping Zhang · 2022 · Natural Product Communications
  33. Community Series - Liver Fibrosis and MAFLD: from Molecular Aspects to Novel Pharmacological Strategies, Volume II
    2024 · Frontiers research topics
  34. IDOL alleviates the body weight by upregulating UCP ‐1 in mice
    Hua Guan, Le Wang, Chengcheng Tang, Hao Xu, Aoqi Xiang, Xiaochang Chen, Qi Yu, Lixian Xu · 2025 · Diabetes Obesity and Metabolism
  35. Reelin regulates migration and differentiation of extravillous trophoblastic cells: Implications for Preeclampsia
    Nicole Sommer, Aníbal Pacheco, Jorge Carvajal C, Hugo C. Olguín, Andrea Leiva, Jaime Gutiérrez, María‐Paz Marzolo · 2025 · Research Square
  36. VLDLR: A Multifunctional receptor in diverse pathophysiological processes
    Xinyu Wang, Yan Chen, Jinmei Wei, Yanling Li, Juan Xu, Tao Dai, Ning Tang, Chen Han, Yanhong Zhou · 2026 · Cell Communication and Signaling
  37. Reelin regulates the migration and differentiation of extravillous trophoblastic cells
    Nicole Sommer, Carlos Alarcón-Godoy, Héctor Pizarro, Aníbal Pacheco, Jorge A. Carvajal, Hugo C. Olguín, Jaime Gutiérrez, Andrea Leiva, María‐Paz Marzolo · 2026 · Biological Research
  38. Nouveaux modèles pour le criblage de modulateurs / perturbateurs des voies de signalisation régulées par les Liver X receptors
    Allan Fouache · 2018
  39. Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes
    Aseel A. Jawabri, Ainara Salazar‐Villacorta, Henriette V.F. Senghor, Rokhaya Ndiaye, Alia Al-Mehrzi, Amadou Gallo Diop, Moustapha Ndiaye, Bassam R. Ali, Pedro María Rodríguez Cruz · 2026 · Human Mutation
  40. Genome-wide CRISPR screens identify an RXR–MYLIP–LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas
    Keito Yokoyama, Masahiro Chiba, Norio Takei, Keito Suto, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Marshall E. Kadin, Michiyuki Maeda, Masashi Watanabe et al. · 2026 · Oncogene
  41. The E3 ubiquitin ligase IDOL suppresses PRRSV replication by targeting viral Nsp3 for SQSTM1-mediated selective autophagic degradation
    Jiecong Yan, Yuhan Wu, Huirui Xu, Pengning Lai, Ling Huang, Zhan He, Yongsheng Xie, Chunhe Guo · 2026 · mBio
  42. Genetic variation in MYLIP is associated with lipid, thyroid, liver, and hematologic traits in women
    Marie Klevjer, Ada Nilsen Nordeidet, Georgios Kararigas, Anja Bye · 2026 · Scientific Reports